Literature DB >> 20190689

Newly symptomatic central diabetes insipidus in ESRD with adult polycystic kidney disease following intracranial hemorrhage: the first reported case.

Macaulay A C Onuigbo1, Joseph Skalski.   

Abstract

BACKGROUND: Adult polycystic kidney disease (ADPKD), an autosomal dominantly inherited cause of ESRD, is often characterized by a relative renal tubular unresponsiveness to ADH. Polyuria, renal concentrating defects and generally elevated ADH levels, a form of nephrogenic diabetes insipidus (NDI) is often implicated. Thus, even late in stages of CKD, ADPKD patients often produce significant amounts of urine. Conversely, central diabetes insipidus (CDI), a clinical syndrome secondary to deficiency of ADH, also leads to production of large volumes of dilute urine, i.e. polyuria. It is widely believed that clinical CDI is masked in ESRD patients on dialysis, due to apparently obvious reasons. However, there have been published a few reports of the unmasking of polyuria secondary to previously existing CDI in ESRD patients, after kidney transplantation. CASE REPORT: We report, to our knowledge, the first case of new-onset symptomatic CDI causing nocturnal polyuria in an ADPKD patient with ESRD, before now on hemodialysis. CDI symptoms were noted, months after an intracranial aneurysm clipping procedure that was complicated by intra-cranial hemorrhage. The 59-year old Caucasian woman responded moderately to desmopressin replacement therapy.
CONCLUSIONS: Several interesting pathobiologic implications of this case report are entertained.

Entities:  

Mesh:

Year:  2010        PMID: 20190689

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  3 in total

1.  Unmasking of undiagnosed pre-existing central diabetes insipidus after renal transplantation.

Authors:  David D W Kim; Ian M Holdaway
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

2.  Diabetes insipidus as a main symptom of cancer.

Authors:  Lukasz Cieszynski; Lukasz Obolonczyk; Krzysztof Sworczak; Monika Berendt-Obolonczyk; Malgorzata Siekierska-Hellmann
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

3.  Optimizing HgA1C and glucose monitoring frequency in patients with Type 2 diabetes.

Authors:  Juanita F Bridges; Daniel Brignac; Sequria Thomas; Carmen Kent; Marilyn Ogbuli; Jeanne Draper; Helen Rasumssen; Akane Daniels; Darlene Cook; Caroline Chartier; Lauren Brewer; Hani Mesak
Journal:  Med Sci Monit       Date:  2012-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.